InvestorsHub Logo
Followers 30
Posts 1397
Boards Moderated 0
Alias Born 07/14/2011

Re: namtae post# 712

Friday, 03/31/2017 2:14:50 PM

Friday, March 31, 2017 2:14:50 PM

Post# of 28488
First

It needs to trade for 1 second at or above $4 for the uplisting. At current levels that could be accomplished with a 1 for 15.

Revenue was down, but sales...both new and consumables were up and revenues were also hit with decreased grant money.

Sales staff has increased as has potential market share given the CE mark.

They just were awarded a fairly prestigious new instrument award....which means little to you or I, but I contest, matters in the world of research scientists looking to add new instruments.

The cancer moonshot funding has yet (as far as I know) to be allocated and they are positioned to receive government contract money.

They still have the rape kit collaboration going which again opens the door to more government contract money.

Sales have grown q over q with little to no sales force.

Current sales have a direct link to Sciex which if you would call Richard or listen to the CC's you'd know.

As I have said...repeatedly...you don't have to invest, but you don't have to paint a negative picture on a company that is doing a very good job at growing in a very difficult and competitive market place.

Lastly all the convertibles and offerings are equally impacted post split. Again, information that you would know if you called and talked to Richard.

Best of luck
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBIO News